Alligo - Tooled up for continued margin recovery
Q3e: Sales SEK 2,346m and adj. EBITA SEK 177mEstimates trimmed by 4/2% for '26e/'27e12x/10x '26e/'27e adj. EBITAQ3 expectationsWe expect the company t...
- Alligo
- Arctic Paper
- Ascelia Pharma
- BTS Group
- Byggmästaren
- Careium
- Catella
- Cavotec
- Clavister
- Coeli Private Equity
- Coor
- CTT Systems
- Donkey Republic
- Eastnine
- Eltel
- Embellence Group
- ES Group AB
- Ework Group
- Fastpartner
- Ferronordic
- G5 Entertainment
- Generic
- Gentoo Media
- Impact Coatings
- Infrea
- Inission
- Isofol Medical
- I-tech
- Lumi Gruppen
- Medicover
- Midsona
- Nepa
- Nexam Chemical
- Nolato
- NYAB
- Ogunsen
- OssDsign
- Ovzon
- Petrolia Noco
- Prevas
- Proact
- Qben Infra
- Qliro
- SinterCast
- Skolon
- Stenhus Fastigheter
- StrongPoint
- Svedbergs Group
- Tempest Security
- Viscaria
- Xplora Technologies
Press the button and be introduced to a new random company!
Social media
Follow us on Twitter
Latest Equity Research
Cavotec - MoorMaster order adds to positive momentum
Q3 report due Tuesday 6 NovemberOrder intake to remain positive13-9x '27e-'28e EV/EBITQ3 expectationsWe expect order momentum to remain positive in Q3...
Coeli Private Equity - NAV growth continues, discount widens
NAV per share +7.2% y-o-yBuyback and net cash position support continued 5-7% dividend~35% NAV discount vs ~22% average; fair value range SEK 100-136N...
Qliro - Growth moderates, scaling continues
Steady growth despite Enterprise cautionEarnings trajectory shifts further outScaling to drive profitabilitySteady growth despite near-term Enterprise...
Gentoo Media - Guidance downgrade and new financing
Guidance downgrade following Brazil banNew financing includes both a new loan and an equity raiseTrading at 4x '27e P/E at the subscription price of t...
Svedbergs Group - Swedish savings boost '27e EBITA by 2%
Q3e EBITA +11% y-o-y to SEK 88mWe raise '27e EBITA 2% on Svedbergs savingsWe reiterate our fair value range of SEK 57-77We expect EBITA +11% y-o-y in ...
Ovzon - Lukewarm Q3 on the cards
Sequential sales decline, but order activity has improvedWe cut '26e-'28e EBIT by 11-8% on lower sales assumptions16-13x '26e-'27e EV/EBITSequential s...
Show more